Mastodon

Zopiclone (Tablets) Instructions for Use

ATC Code

N05CF01 (Zopiclone)

Active Substance

Zopiclone (Rec.INN registered by WHO)

Clinical-Pharmacological Group

Hypnotic drug

Pharmacotherapeutic Group

Hypnotic agent

Pharmacological Action

A hypnotic agent from the group of cyclopyrrolone derivatives. A “non-benzodiazepine” agonist of benzodiazepine receptors. It also possesses sedative, anxiolytic, central muscle relaxant, anticonvulsant, and amnestic properties.

Similar to benzodiazepine derivatives, Zopiclone enhances GABAergic processes in the brain by interacting with benzodiazepine receptors, which increases the sensitivity of GABA receptors to the neurotransmitter. However, Zopiclone appears to interact with different sites of the benzodiazepine receptor than benzodiazepines.

Zopiclone reduces sleep latency, decreases the number of nocturnal awakenings, and increases total sleep duration. It has virtually no effect on sleep structure and does not significantly reduce the amount of REM sleep. Hangover effects upon awakening are absent or mild. Repeated administration of zopiclone is not accompanied by accumulation.

Pharmacokinetics

Rapidly and completely absorbed from the gastrointestinal tract. Cmax is achieved in 1-3 hours. Easily passes through histohematic barriers, including the blood-brain barrier, and is distributed to organs and tissues, including the brain. T1/2 is 5.5-6 hours; does not accumulate.

Indications

Sleep disorders (difficulty falling asleep, frequent nocturnal awakenings, early morning awakening), transient, situational, and chronic insomnia; sleep disorders in mental disorders; bronchial asthma with nocturnal attacks (in combination with a single daily dose of theophylline).

ICD codes

ICD-10 code Indication
F51.0 Nonorganic insomnia
F51.2 Nonorganic disorders of the sleep-wake schedule
J45 Asthma
ICD-11 code Indication
7A00 Chronic insomnia
7A01 Acute insomnia
7A0Z Insomnia disorders, unspecified
7B2Z Sleep-wake cycle disorders, unspecified
CA23 Asthma

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take the tablet orally immediately before bedtime. Ensure you have a period of uninterrupted sleep of 7-8 hours after ingestion.

The standard adult dose is 7.5 mg once daily. For severe insomnia, the dose may be increased to a maximum of 15 mg.

For elderly patients, initiate therapy at a reduced dose of 3.75 mg. Use the same reduced dose for patients with hepatic impairment.

Limit the treatment duration to a maximum of 4 weeks. Avoid prolonged use to minimize the risk of dependence and tolerance.

Do not take the medication with or immediately after a high-fat meal, as this can delay the onset of action.

Do not crush or chew the tablet. Swallow it whole with a glass of water.

Adverse Reactions

From the digestive system: sensation of a bitter or metallic taste in the mouth, dry mouth, nausea, vomiting.

From the central nervous system: dizziness, headache, drowsiness, confusion, anterograde amnesia, hallucinations, nightmares.

Dermatological reactions: skin rash.

Contraindications

Severe respiratory failure, pregnancy, lactation (breastfeeding), children and adolescents under 15 years of age, hypersensitivity to zopiclone.

Use in Pregnancy and Lactation

Zopiclone is contraindicated for use during pregnancy and during lactation (breastfeeding).

Use in Hepatic Impairment

Use with caution in severe hepatic insufficiency.

Pediatric Use

Contraindicated in children under 15 years of age.

Special Precautions

Use with caution in severe hepatic insufficiency.

The risk of drug dependence is minimal if the duration of zopiclone use does not exceed 4 weeks. However, the potential danger of developing dependence on zopiclone exists.

During treatment, alcohol consumption should be avoided.

Influence on the ability to drive vehicles and operate machinery

The day after taking the drug, one should exercise caution when driving a car and working with machinery.

Drug Interactions

With simultaneous use, it reduces the plasma concentration of trimipramine and its effect.

Zopiclone enhances the effect of drugs that depress the central nervous system (including ethanol).

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Slovakofarma J.S.C. (Slovakia)

Dosage Form

Bottle Rx Icon Zopiclone 7.5-SL Tablets 7.5 mg: 10 or 20 pcs.

Dosage Form, Packaging, and Composition

Film-coated tablets 1 tab.
Zopiclone 7.5 mg

10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (2) – cardboard packs.

Marketing Authorization Holder

Lekpharm, SOOO (Republic of Belarus)

Dosage Form

Bottle Rx Icon Zopiclone-Lekpharm Film-coated tablets, 7.5 mg: 10 or 30 pcs.

Dosage Form, Packaging, and Composition

Film-coated tablets green, round, biconvex in shape.

1 tab.
Zopiclone 7.5 mg

Excipients: microcrystalline cellulose 102 – 61.2 mg, sodium carboxymethyl starch (type A) – 5.1 mg, magnesium stearate – 1.7 mg, calcium hydrogen phosphate dihydrate – 61.2 mg, lactose monohydrate – 33.3 mg.

Shell composition Opadry II green (85F21738) (partially hydrolyzed polyvinyl alcohol – 3.2 mg, titanium dioxide (E171) – 1.9476 mg, macrogol – 1.616 mg, talc – 1.184 mg, indigo carmine aluminum lake dye (E132) – 0.0432 mg, quinoline yellow aluminum lake dye (E104) – 0.0092 mg) – 8 mg.

10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.

TABLE OF CONTENTS